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ABSTRACT
Introduction. This is the 2018 Annual Report of the Kansas 
Poison Control Center at The University of Kansas Health System 
(KSPCC). The KSPCC serves the state of Kansas 24-hours per day, 
365 days a year with certified specialists in poison information and 
clinical and medical toxicologists. 
Methods.xAll encounters reported to the KSPCC from January 1, 
2018 through December 31, 2018 were analyzed. Data recorded for 
each exposure included caller location, age, weight, gender, expo-
sure substance, nature of exposure, route of exposure, interventions, 
medical outcome, disposition, and location of care.
Results. There were 21,072 total encounters, including 20,031 
human exposure cases. Calls were received from every county and 
hospital in Kansas. Most of the exposures involved females (51.5%, 
n = 10,320) and a child less than 19 year of age (64%, n = 12,865). 
Medical outcomes were 24.5% (n = 4,912) no effect, 17.7% (n = 3,542) 
minor effect, 9.1% (n = 1,830) moderate effect, and 2.4% (n = 476) 
major effect. Seven deaths were reported in 2018. The number of 
exposure calls from healthcare facilities and severity of medical out-
comes increased in 2018 compared to 2017. 
Conclusion. The 2018 KSPCC annual report demonstrated that 
the center receives calls from the entire state of Kansas totaling over 
20,000 human exposures. While pediatric exposures remain the 
most common encounter, a trend continued of an increasing number 
of calls from healthcare facilities and for cases with serious outcomes. 
This report supported the continued value of the KSPCC to both 
public and acute health care in the state of Kansas. 
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INTRODUCTION
This is the 2018 Annual Report of Kansas Poison Control Center 
at The University of Kansas Health System (KSPCC). The KSPCC 
is a 24-hour, 365 day-a-year health care information resource 
serving the state of Kansas. It was founded in 1982 and is one of the 
55 poison control centers certified by the American Association of 
Poison Control Centers (AAPCC) in the United States. The KSPCC 
is staffed by nine certified specialists in poison information who are 
either critical care trained nurses or doctors of pharmacy. There is 
24-hour back-up provided by board certified clinical and medical 
toxicologists. 
The KSPCC receives calls from the public, law enforcement, 
health care professionals, and public health agencies. Encounters 
may involve an exposed animal or human (Exposure Call) or a 
request for information with no known exposure (Information Call). 
The KSPCC follows all cases to make management recommenda-
tions, monitor case progress, and document medical outcome. This 
information is recorded electronically in the Toxicall® data manage-
ment system and uploaded in near real-time to the National Poison 
Data System (NPDS). 
NPDS is the data warehouse for all the nation’s poison control 
centers.1 The average time to upload data for all poison centers is 8.07 
[7.32, 12.65] (median [25%, 75%]) minutes, creating a near real-time 
national exposure database and surveillance system. The KSPCC has 
the ability to share NPDS real time surveillance with state and local 
health departments and other regulatory agencies. An analysis and 
summary of all encounters reported to the KSPCC from January 1, 
2018 through December 31, 2018 follows.
METHODS
All KSPCC encounters recorded electronically in the Toxicall® 
data management system from January 1, 2018 to December 31, 
2018 were analyzed. Cases were first classified as either an expo-
sure or suspected exposure (Human Exposure, Animal Exposure, 
Non-Exposure Confirmed Cases) or a request for information with 
no reported exposure (Information Call). Data extracted included: 
caller location, age, weight, gender, exposure substance, number 
of follow up calls, nature of exposure (unintentional, recreational, 
or intentional), exposure scenario, route of exposure (oral, dermal, 
parenteral), interventions, medical outcome (no effect, minor, mod-
erate, severe or death), disposition (admitted to noncritical care unit, 
admitted to critical care unit, admitted to psychiatry unit, lost to fol-
low-up, or treated and released) and location of care (non-health care 
facility or health care facility). 
For this analysis a pediatric case was defined as any patient 19 
years of age or less. This is consistent with NPDS methodology. Simi-
larly, NPDS descriptions of the medical outcomes of cases were used. 
Minor outcomes are defined as minimally bothersome symptoms 
while moderate outcomes are more pronounced symptoms, usually 
requiring treatment, and major outcomes are life threatening signs 
and symptoms. Data was analyzed using Microsoft® Excel (Microsoft 
Corp, Redmond, WA).
RESULTS
The KSPCC logged 21,072 total calls in 2018, including 20,031 
human exposure cases, 74 non-exposure confirmed cases, 92 animal 
exposure cases, and 875 information calls. This was a decrease of 
359 calls (1.7%) compared to 2017. For information calls, drug infor-
mation (n = 285) was the most common reason for calling. Table 1 
further describes the encounter types. The KSPCC made 30,589 
follow-up calls in 2018. Follow-up calls were done in 54.5% of human 
exposure cases. One follow-up call was made in 23.1% of human 
exposure cases and multiple follow-up calls (range 2 - 45) were made 
in 31.4% of cases. In human exposure calls for which follow-up calls 
were made, an average of 2.8 calls per case were performed, which 
was a 5% increase over 2017.
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Number %
Exposure
Human exposure 20,031 99.5
Animal exposure 92 0.5
Subtotal 20,123 95.5
Non-Exposure Confirmed Cases
Human non-exposure 74 0.4
Subtotal 74 0.4
Information Call
Drug information 285 32.6
Drug identification 94 10.7
Environmental information 97 11.1
Medical information 27 3.1
Occupational information 3 0.3
Poison information 85 9.7
Prevention / Safety / Education 19 2.2
Teratogenicity information 6 0.7
Other information 44 5.0
Substance abuse 7 0.8
Administrative 19 2.2
Caller referred 189 21.6
Subtotal 875 4.1
Total 21,072 100.0
The KSPCC received calls from all 105 counties and every hospital 
in Kansas. The county with the largest number of calls was Sedgwick 
County with 3,218. In addition, calls were received from 46 states, 
the District of Columbia, and the U.S. Virgin Islands, while eight calls 
came from foreign countries including Mexico and Thailand.  
Overall, a slight majority of human exposure cases (51.5%, n = 
10,320) were female. In children younger than 13 years of age, most 
encounters involved a male, but this gender distribution was reversed 
in teenagers and adults. Approximately 64% (n = 12,865) of human 
exposures involved a child (defined as age 19 years or less). Table 2 
illustrates distribution of human exposures by age and gender.
Patients one year of age were the most common age group involved 
in encounters reported to the KSPCC. For adults, the age group of 
20-29 years old was most commonly encountered.  Seventy-three 
exposures occurred in pregnant women (0.4% of all human expo-
sures). Of these exposures, 31.5% occurred in the first trimester, 37% 
occurred in the second trimester, and 28.8% occurred in the third 
trimester. Most of the pregnancy exposures (n = 44, 60.3%) were 
unintentional exposures, but there were 21 (28.8%) intentional expo-
sures. There were no reported deaths to KSPCC in pregnant women 
in 2018. 
For human exposures, 67.2% (n = 13,455) of calls originated from a 
residence (own or other), while 93.5% (n = 18,731) of these exposures 
occurred at a residence (own or other).  Calls from a health care facil-
ity accounted for 25.8% (n = 5,168) of human exposure encounters. 
Table 3 further details the origin of human exposure calls and where 
the exposure took place.
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The majority of human exposures, 85.6 % (n = 17,150), were 
acute cases defined as exposures occurring over eight hours or less. 
Chronic exposures (exposures occurring over eight hours) accounted 
for 2.0% (404) of all human exposures reported. Acute on chronic 
exposures (single exposure that was preceded by a chronic expo-
sure over eight hours) totaled 2,382 (11.9%). Ingestion was the most 
common route of exposure documented (81.9%, n = 17,554) in all 
cases.  Table 4 further details the routes of exposures.
The most common reported substance in those less than six years 
of age was cosmetics/personal care products (n = 1,134) followed 
closely by household cleaning products (n = 1,125). For adult (> 19 
years of age) encounters, analgesics (n = 1,210) and sedatives/ hyp-
notics/antipsychotics (n = 1,147) were the most frequently involved 
substances. Among all encounters, analgesics (n = 2,867, 11.6%) 
were the most frequently encountered substance category. Table 5 
lists most frequently encountered substance categories for pediatric 
encounters and Table 6 lists those for adult encounters. Appendix A 
is a summary log for all exposures categorized by category and sub-
category of substance (available at journals.ku.edu/kjm).
There was a total of 316 plant exposures reported to the KSPCC. 
The most common plant exposure encountered was to pokeweed 
(Phytolacca Americana; n = 44). Table 7 lists the top five most 
encountered plants.
Unintentional exposures were the most common reason for expo-
sures (76.7%, n = 15,364), while intentional exposures accounted 
for 20.7% (n = 4,140) of exposures. Table 8 lists reasons for human 
exposures. A majority of unintentional exposures, 63.5% (n = 9,759), 
occurred in the ≤ 5-year-old age group. Up to 12 years of age, 98.2% 
(n = 10,830) of ingestions were unintentional. However, in the 13 - 
19-year-old group, intentional exposure was most common (69.5%, 
n = 1,277). In total, suspected suicide attempts accounted for 15.7% 
(n = 3,138) of human encounters. When a therapeutic error was the 
reason for exposure, a double dose was the most common scenario, 
30% (n = 760). Table 8 demonstrates all reasons for human expo-
sures.
Most encounters (67.4%, n = 13,503) were managed in a non-health 
care facility (i.e., a residence). Of the 6,321 encounters managed at a 
health care facility, 46.1% (n = 2,904) were admitted. Table 9 lists the 
management site of all human encounters.
Among human exposures, 15,132 involved exposures to 
pharmaceutical agents, while 9,510 involved exposure to non-
pharmaceuticals. Because an encounter could include numerous 
pharmaceutical agents and non-pharmaceutical agents, this total 
is greater than the total number of encounters. However, 86.8% 
(n = 17,389) of all human exposures were exposed to only a single 
substance. Among these single substance exposures, the reason for 
exposure was intentional in 24.5% (n = 2,188) of pharmaceutical-
only cases compared to 3.8% (n = 323) of non-pharmaceutical single 
substance exposures.
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Table 2. Distribution of human exposures by age and gender. 
Male Female Unknown Gender Total Cumulative Total
Age (yrs.) N
% of age 
group 
total
N
% of age 
group 
total
N % of age group total N
% of total 
exposure N %
< 1 year 595 54.09 503 45.73 2 0.18 1,100 5.49 1,100 5.49
1 year 1,674 52.81 1,494 47.13 2 0.06 3,170 15.83 4,270 21.32
2 years 1,548 51.48 1,457 48.45 2 0.07 3,007 15.01 7,277 36.33
3 years 798 56.80 607 43.20 0 0.00 1,405 7.01 8,682 43.34
4 years 400 55.56 317 44.03 3 0.42 720 3.59 9,402 46.94
5 years 238 60.41 156 39.59 0 0.00 394 1.97 9,796 48.90
Unknown ≤ 5 years 0 0.00 1 100.00 0 0.00 1 0.00 9,797 48.91
Child 6-12 years 689 56.34 531 43.42 3 0.25 1,223 6.11 11,020 55.01
Teen 13-19 years 660 35.91 1,177 64.04 1 0.05 1,838 9.18 12,858 64.19
Unknown Child 1 14.29 3 42.86 3 42.86 7 0.03 12,865 64.23
Subtotal 6,603 51.33 6,246 48.55 16 0.12 12,865 64.23 12,865 64.23
20-29 years 862 46.15 1,006 53.85 0 0.00 1,868 9.33 14,733 73.55
30-39 years 678 43.80 867 56.01 3 0.19 1,548 7.73 16,281 81.28
40-49 years 415 39.79 626 60.02 2 0.19 1,043 5.21 17,324 86.49
50-59 years 387 40.40 570 59.50 1 0.10 958 4.78 18,282 91.27
60-69 years 343 42.77 458 57.11 1 0.12 802 4.00 19,084 95.27
70-79 years 221 42.75 296 57.25 0 0.00 517 2.58 19,601 97.85
80-89 years 88 36.97 150 63.03 0 0.00 238 1.19 19,839 99.04
≥ 90 years 18 40.91 26 59.09 0 0.00 44 0.22 19,883 99.26
Unknown adult 48 41.74 67 58.26 0 0.00 115 0.57 19,998 99.84
Subtotal 3,060 42.90 4,066 57.00 7 0.10 7,133 35.61 19,998 99.84
Unknown age 12 36.36 8 24.24 13 39.39 33 0.16 20,031 100.00
Total* 9,675 48.30 10,320 51.52 36 0.18 20,031 100.00 20,031 100.00
*Total includes 33 unknown age cases. 
Table 3. Origin of call and site of exposure for human exposure cases.
Site Origin of Call Site of Exposure
 N % N %
Residence
Own 13,110 65.45 18,064 90.18
Other 345 1.72 667 3.33
Workplace 307 1.53 443 2.21
Health care facility 5,168 25.80 75 0.37
School 38 0.19 271 1.35
Restaurant/food service 4 0.02 36 0.18
Public area 75 0.37 161 0.80
Other 963 4.81 222 1.11
Unknown 21 0.10 92 0.46
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Table 4. Route of human exposures.
 Human Exposures
Route N % of All Routes % of All Cases
Ingestion 17,554 81.94 87.63
Dermal 1,577 7.36 7.87
Inhalation/nasal 1,014 4.73 5.06
Ocular 709 3.31 3.54
Bite/sting 190 0.89 0.95
Unknown 172 0.80 0.86
Parenteral 156 0.73 0.78
Other 17 0.08 0.08
Otic 13 0.06 0.06
Rectal 10 0.05 0.05
Aspiration (with ingestion) 5 0.02 0.02
Vaginal 5 0.02 0.02
Total Number of Routes 21,422* 100.00 106.94*
*Some cases may have multiple routes of exposure documented. 
Table 5. Substance categories most frequently involved in exposure for age ≤ 5 years old.
Substance Category All Substance % Single Substance Exposures %
Cosmetics/Personal Care Products 1,134 11.04 1,110 11.69
Cleaning substances (Household) 1,125 10.96 1,080 11.37
Analgesics 925 9.01 853 8.98
Foreign bodies/toys/miscellaneous 587 5.72 575 6.05
Antihistamines 578 5.63 512 5.39
Dietary supplements/herbals/homeopathic 472 4.60 437 4.60
Vitamins 451 4.39 404 4.25
Topical preparations 441 4.29 434 4.57
Pesticides 386 3.76 377 3.97
Gastrointestinal preparations 281 2.74 254 2.67
Cold and cough preparations 226 2.20 209 2.20
Cardiovascular drugs 222 2.16 151 1.59
Essential oils 215 2.09 208 2.19
Antimicrobials 204 1.99 189 1.99
Plants 201 1.96 196 2.06
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Table 6. Substance categories most frequently involved in exposures of adults (≥ 20 years). 
Substance Category All Substance % Single Substance Exposures %
Analgesics 1,210 11.50 559 10.45
Sedative/hypnotics/antipsychotics 1,147 10.91 315 5.89
Antidepressants 955 9.08 311 5.81
Cardiovascular drugs 761 7.24 249 4.65
Alcohols 535 5.09 67 1.25
Antihistamines 471 4.48 202 3.77
Anticonvulsants 463 4.40 142 2.65
Cleaning substances (Household) 445 4.23 348 6.50
Pesticides 366 3.48 327 6.11
Hormones and hormone antagonists 328 3.12 175 3.27
Stimulants and street drugs 303 2.88 131 2.45
Chemicals 244 2.32 206 3.85
Cosmetics/personal care products 224 2.13 198 3.70
Fumes/gases/vapors 212 2.02 190 3.55
Muscle relaxants 210 2.00 68 1.27
Table 7. Top 5 most frequent plant exposures. 
Botanical Name or Category N
Phytolacca americana (L.) (Botanic name) 44
Cherry (Species unspecified) 18
Plants -Toxicodendrol 16
Philodendron (Species unspecified) 13
Spathiphyllum species (Botanic name) 10
Plants-general-unknown 22
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Table 8. Reason for human exposure cases. 
Unintentional
Unintentional - general 10,383 51.8
Unintentional - therapeutic error 2,446 12.2
Unintentional - misuse 1,381 6.9
Unintentional - environmental 485 2.4
Unintentional - occupational 325 1.6
Unintentional - bite/sting 191 1.0
Unintentional - food poisoning 139 0.7
Unintentional - unknown 14 0.1
Subtotal 15,364 76.7
Intentional
Intentional - suspected suicide 3,138 15.7
Intentional - misuse 533 2.7
Intentional - abuse 382 1.9
Intentional - unknown 87 0.4
Subtotal 4,140 20.7
Adverse reaction
Adverse reaction - drug 249 1.2
Adverse reaction - other 56 0.3
Adverse reaction - food 49 0.2
Subtotal 354 1.8
Unknown
Unknown reason 90 0.4
Subtotal 90 0.4
Other
Other - malicious 52 0.3
Other - withdrawal 19 0.1
Other - contamination/tampering 12 0.1
Subtotal 83 0.4
Total 20,031 100.0
Table 9. Management site of human exposures. 
Site of Management N %
Managed in healthcare facility
Treated/evaluated and released 3,211 16.0
Admitted to critical care unit 1,520 7.6
Admitted to noncritical care unit 826 4.1
Admitted to psychiatric facility 558 2.8
Patient lost to follow-up/left AMA 206 1.0
Subtotal (managed in Healthcare facility) 6,321 31.6
Managed on site, non-health care facility 13,503 67.4
Other 15 0.1
Refused referral 177 0.9
Unknown 15 0.1
Total 20,031 100.0
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When medical outcomes were analyzed, 24.5% (n = 4,912) of 
human exposures had no effect, 17.7% (n = 3,542) had minor effect, 
9.1% (n = 1,830) had moderate effect, and 2.4% (n = 476) major effect. 
Moderate effects were more common in the 13 - 19-year-old group, 
while major effects were more common in those over 20 years of 
age. Moderate and major effects were most common in those with 
intentional encounters. More serious outcomes were related to sin-
gle-substance pharmaceutical exposures, accounting for 42.9% (n 
= 3) of the fatalities. Table 10 lists all medical outcomes by age and 
Table 11 lists outcomes by reason for exposure. 
Use of decontamination and specific therapies, including antidotal 
therapy, is detailed in tables 12a and 12b. 
There were seven deaths in 2018 reported to the KSPCC. All 
deaths involved patients 20 years of age or older. Five of the deaths 
involved intentional exposures. Table 13 details the seven reported 
deaths.
Table 14 compares key statistics from 2015 to 2018. Total num-
ber of calls has declined since 2016. However, number of exposures 
calls from healthcare facilities and those involving moderate or 
major outcomes have steadily increased from 2015 to 2018. The 
number of reported deaths decreased from 2017 to 2018.
Table 10. Medical outcome of human exposure cases by patient age. 
 ≤ 5 Years 6-12 Years 13-19 Years ≥ 20 Years Unknown Child
Unknown 
Adult
Unknown 
Age Total
Outcome N % N % N % N % N % N % N % N %
No effect 2,962 30.23 254 20.77 478 26.01 1,203 17.14 3 42.86 8 6.96 4 12.1 4,912 24.52
Minor effect 1,008 10.29 238 19.46 530 28.84 1,736 24.74 1 14.29 25 21.74 4 12.1 3,542 17.68
Moderate effect 112 1.14 52 4.25 360 19.59 1,298 18.50 0 0.00 3 2.61 5 15.2 1,830 9.14
Major effect 14 0.14 3 0.25 82 4.46 375 5.34 0 0.00 1 0.87 1 3.0 476 2.38
Death 0 0.00 0 0.00 0 0.00 7 0.10 0 0.00 0 0.00 0 0.0 7 0.03
No follow-up, 
nontoxic 341 3.48 44 3.60 5 0.27 39 0.56 0 0.00 1 0.87 0 0.0 430 2.15
No follow-up, 
minimal toxicity 5,032 51.36 580 47.42 288 15.67 1,766 25.16 3 42.86 39 33.91 10 30.3 7,718 38.53
No follow-up, 
potentially toxic 230 2.35 15 1.23 55 2.99 282 4.02 0 0.00 29 25.22 9 27.3 620 3.10
Unrelated effect 98 1.00 37 3.03 40 2.18 312 4.45 0 0.00 9 7.83 0 0.0 496 2.48
Death, indirect 
report 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.0 0 0.00
Total 9,797 100.00 1,223 100.0 1,838 100.00 7,018 100.00 7 100.00 115 100.00 33 100.00 20,031 100.00
 
Table 11. Medical outcome by reason for exposure in human exposures. 
 Unintentional Intentional Other Adverse Reaction Unknown Total
Outcome N % N % N % N % N % N %
Death 1 0.01 5 0.12 0 0.00 1 0.28 0 0.00 7 0.03
Death, indirect report 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Major effect 46 0.30 405 9.78 7 8.43 8 2.26 10 11.11 476 2.38
Minor effect 2,280 14.84 1,138 27.49 16 19.28 96 27.12 12 13.33 3,542 17.68
Moderate effect 540 3.51 1,194 28.84 19 22.89 55 15.54 22 24.44 1,830 9.14
No effect 3,900 25.38 983 23.74 5 6.02 13 3.67 11 12.22 4,912 24.52
No follow-up, nontoxic 420 2.73 7 0.17 0 0.00 1 0.28 2 2.22 430 2.15
No follow-up, minimal toxicity 7,422 48.31 179 4.32 17 20.48 94 26.55 6 6.67 7,718 38.53
No follow-up, potentially toxic 424 2.76 158 3.82 13 15.66 12 3.39 13 14.44 620 3.10
Unrelated effect 331 2.15 71 1.71 6 7.23 74 20.90 14 15.56 496 2.48
Total 15,364 100.00 4,140 100.00 83 100.00 354 100.00 90 100.00 20,031 100.00
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Table 12a. Decontamination provided in human exposures by age. 
Decontamination ≤ 5 Years 6-12 Years 13-19 Years ≥ 20 Years Unknown Child Unknown Adult Unknown Age Total
Cathartic 2 0 2 1 0 0 0 5
Charcoal, multiple 
doses 3 0 8 8 0 0 0 19
Charcoal, single dose 62 11 132 197 0 0 0 402
Dilute/irrigate/wash 7,404 727 402 2,531 2 47 10 11,123
Food/snack 1,436 132 85 422 2 5 1 2,083
Fresh air 68 52 32 419 0 19 9 599
Lavage 0 0 0 0 0 0 0 0
Other emetic 67 6 7 49 0 0 0 129
Whole bowel irrigation 0 0 1 13 0 0 0 14
Table 12b. Therapy provided in human exposures by age. 
Therapy ≤ 5 Years 6-12 Years 13-19 Years ≥ 20 Years Unknown Child Unknown Adult Unknown Age Total
Decontamination
Cathartic 2 0 2 1 0 0 0 5
Charcoal, multiple doses 3 0 8 8 0 0 0 19
Charcoal, single dose 62 11 132 197 0 0 0 402
Dilute/irrigate/wash 7,404 727 402 2,531 2 47 10 11,123
Food/snack 1,436 132 85 422 2 5 1 2,083
Fresh air 68 52 32 419 0 19 9 599
Ipecac 0 0 0 2 0 0 0 2
Other emetic 67 6 7 49 0 0 0 129
Whole bowel irrigation 0 0 1 13 0 0 0 14
Other Therapies
Alkalinization 2 0 47 162 0 0 0 211
Antiarrhythmic 0 0 0 3 0 0 0 3
Antibiotics 17 9 15 171 0 0 0 212
Anticonvulsants 0 0 3 2 0 0 0 5
Antiemetics 13 11 121 255 0 0 0 400
Antihistamines 14 6 15 79 0 1 1 116
Antihypertensives 0 0 0 18 0 0 0 18
Antivenom (Immune Fab 
fragment) – Not Specified 1 3 2 22 0 0 0 28
Antivenom/antitoxin (Non-Fab) 
–  Not Specified 0 2 0 8 0 0 0 10
Atropine 4 2 3 9 0 1 0 19
Benzodiazepines 12 7 109 345 0 0 1 474
Bronchodilators 5 6 7 67 0 1 0 86
Calcium 126 8 10 35 0 0 0 179
Cardioversion 0 0 0 1 0 0 0 1
Deferoxamine 0 0 0 1 0 0 0 1
Digoxin Immune Fab 0 0 0 12 0 0 0 12
EDTA 1 0 0 0 0 0 0 1
Ethanol 0 0 0 1 0 0 0 1
Extracorp. procedure (other) 0 0 0 1 0 0 0 1
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Table 12b. Therapy provided in human exposures by age. cont.
Therapy ≤ 5 Years 6-12 Years 13-19 Years ≥ 20 Years Unknown Child Unknown Adult Unknown Age Total
Fluids, IV 53 31 525 1,535 0 3 0 2,147
Flumazenil 2 3 2 35 0 0 0 42
Folate 0 0 0 5 0 0 0 5
Fomepizole 0 1 1 24 0 0 0 26
Glucagon 1 0 3 25 0 1 0 30
Glucose, > 5% 3 0 5 48 0 1 0 57
Hemodialysis 0 0 1 24 0 0 0 25
Hyperbaric oxygen 0 0 0 4 0 0 0 4
Insulin 0 0 6 22 0 1 0 29
Intubation 3 0 30 205 0 1 0 239
Methylene blue 0 0 0 4 0 0 0 4
NAC, IV 3 4 76 177 0 0 0 260
NAC, PO 0 0 14 24 0 0 0 38
Nalmefene 0 0 0 1 0 0 0 1
Naloxone 10 3 28 139 0 1 0 181
Neuromuscular blocker 0 0 2 13 0 0 0 15
Octreotide 2 0 0 2 0 0 0 4
Other 42 27 98 534 0 2 0 703
Oxygen 9 4 52 435 0 1 4 505
Physostigmine 0 0 4 5 0 0 0 9
Phytonadione 1 0 7 21 0 0 0 29
Sedation (other) 7 1 33 213 0 0 0 254
Steroids 9 7 8 66 0 1 0 91
Succimer 7 0 0 7 0 0 0 14
Transplantation 0 0 0 1 0 0 0 1
Vasopressors 2 0 8 53 0 1 0 64
Ventilator 2 0 32 197 0 1 0 232
DISCUSSION
The 2018 Kansas Poison Control Center at The University of 
Kansas Health System’s statistics are mirroring those seen nation-
ally by the other 54 accredited poison control centers nationwide. In 
2018,  2,530,238 encounters were logged by poison control, including 
2,099,751 human exposures.1 Overall encounters showed a 2.96% 
(n = 77,175) decline from 2017 to 2018, though healthcare facility 
human exposure cases decreased by only 0.261% from 2017. More 
serious outcomes (moderate, major or death) continue to increase. 
Nationwide, the five substance classes most frequently involved in 
adult exposures were analgesics, cleaning substances (household), 
cosmetics/personal care products, sedative/hypnotics/antipsychot-
ics, and antidepressants, while the top five most common exposures 
in children age five years or less were cosmetics/personal care prod-
ucts, household cleaning substances, analgesics, foreign bodies/toys/
miscellaneous, and topical preparations. There were 3,111 exposure 
related fatalities reported nationwide in 2018.
The KSPCC has served the state of Kansas continually 24 hours a 
day, 365 days a year for 37 years. By receiving over 20,000 calls per 
year, the KSPCC continues to be an important resource for emergen-
cy medical services, public health agencies, and health care facilities 
in Kansas. Childhood poisonings, both unintentional and intentional, 
remain a major focus since calls for patients under 19 years of age 
account for approximately 2/3 of all exposures. However, more 
serious hospitalized adult cases are becoming an increasing trend.
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Table 13. Details on deaths and exposure related fatalities. 
Age; Sex Substances Substance Rank Cause Rank Chronicity Route Reason AAPCC RCF*
53;F Acetaminophen/
Diphenhydramine 1 1 A/C Ingestion Intentional- unknown 3
Metaxalone 2 2
60;F Theophylline 1 1 C Ingestion Adverse reaction - drug 3
34;M Acetaminpphen/ 
Dextromethorphan/Doxylamine 1 1 A Ingestion Intentional - suicide 3
Tramadol 2 2
39;F Quetiapine 1 1 A Ingestion Unknown 4
Trazodone 2 2
Duloxetine 3 3
Potassium Chloride 4 4
Drug, unknown 5 5
65;M Methamphetamine 1 1 A Inhalation Intentional -Abuse 3
59;M Drug, unknown 1 1 A/C Ingestion Intentional - Suicide 6
69;F Drug, unknown 1 1 A Unknown Intentional - Suicide 6
Citalopram 2 2
Baclofen 3 3
*American Association of Poison Control Centers Relative Contribution to Fatality
Table 14. 2015 to 2018 comparison of select statistics. 
2015 2016 2017 2018
Total cases 20,109 21,965 21,431 21,072
Calls from healthcare facility 4,267 4,514 4,892 5,224
Moderate or major outcomes 1,688 1,971 2,170 2,340
Deaths 13 15 16 7
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The ongoing importance of the KSPCC is reflected in trends that 
have seen rates of poisonings and overdoses increase at an alarm-
ing rate over the last decade. According to the most current available 
data, drug poisoning-related hospitalizations in the United States 
have increased 26%.2,3 The National Center for Health Statistics 
noted over 67,000 overdose related deaths in 2018.4 Similarly, the 
KSPCC consistently has seen an increase in the number of calls from 
healthcare facilities and cases with moderate or major medical out-
comes. Over the last four years, calls from healthcare facilities have 
increased by 21%. At the same time, calls involving moderate or ma-
jor outcomes increased by 37%.  
Several limitations must be noted when interpreting poison cen-
ter data. Reporting exposures to the KSPCC is voluntary and the 
KSPCC is not contacted regarding all poisonings in the state of Kan-
sas. Furthermore, in a majority of cases, there is no objective confir-
mation of exposure.
CONCLUSIONS
The 2018 KSPCC annual report demonstrated that the center 
received over 20,000 human exposures called from the entire state 
of Kansas. While pediatric exposures remain the most common, 
there continued to be an increasing trend in the number of calls 
from healthcare facilities and for cases with serious outcomes. In 
this regard, the experience of the KSPCC is similar to national data. 
This report supported the continued value of the KSPCC to both the 
public and healthcare professionals in the state of Kansas.
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